Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2021 · 10-Q
Revenue$33.21M$33.21M+146.7% vs Q3 2020 Net Income$2.02M$2.02M+21.8% vs Q3 2020 EPS Diluted$0.01$0.01— vs Q3 2020 Gross Profit$18,181,000+109.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$10,656,000+899.3% Free Cash Flowderived$3,983,000N/M Margins · derivedGross margin54.7%−9.7 pt vs Q3 2020
Operating margin19.9%−5.3 pt vs Q3 2020
Net margin6.1%−6.2 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 15, 2021 · 46 d after period end